Primary hyperlipoproteinemia and xanthomatosis
Hyperlipidemia is when one or more components and contents of plasma lipids exceed the upper limit of normal. Since plasma lipids are fat-soluble, they must be combined with proteins to form water-soluble complexes to circulate throughout the body, so the phenotype of hyperlipidemia is hyperlipoproteinemia. Xanthoma is a yellow, orange or brownish red papule, nodule or plaque formed by the localized aggregation of lipid-containing tissue cells and macrophages in the dermis, tendons, etc. Patients often have a series of clinical symptoms accompanied by systemic lipid metabolism disorders and abnormalities in other systems, which is called xanthomas.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Inborn errors of metabolism or secondary to underlying diseases -
Related symptoms:
Stomach ache obesity anorexia vascular sclerosis dyslipidemia -
Concurrent disease:
Related Drugs
Orlistat Tablets
Indication: For the treatment of obese or overweight patients (BMI ≥ 24). Orlistat tablets combined with a slightly reduced-calorie diet are indicated for the long-term treatment of obese and overweight patients, including those who have developed risk factors associated with obesity.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Lovastatin Tablets
Indication: Used to treat hypercholesterolemia and combined hyperlipidemia.
Manufacturer:
Chengdu Hengrui Pharmaceutical Co., Ltd.
Lovastatin Tablets
Indication: Used to treat hypercholesterolemia and combined hyperlipidemia.
Manufacturer:
PKU HealthCare Corp., Ltd.
Simvastatin Tablets
Indication: 1. When dietary therapy and other non-drug treatments for hypercholesterolemia are ineffective, simvastatin can be used to reduce total cholesterol and low-density lipoprotein cholesterol in patients with primary hypercholesterolemia. Simvastatin can also increase high-density lipoprotein cholesterol and thus reduce the ratio of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol. In patients with combined hypercholesterolemia and hypertriglyceridemia, when hypercholesterolemia is the main abnormality, it can reduce elevated cholesterol levels; 2. For patients with coronary heart disease, simvastatin is suitable for: reducing the risk of death; reducing the risk of death from coronary heart disease and non-fatal myocardial infarction; reducing myocardial revascularization surgery (coronary artery bypass grafting and percutaneous balloon coronary angioplasty); delaying the progression of atherosclerosis, including the occurrence of new lesions and total blockage.
Manufacturer:
PKU HealthCare Corp., Ltd.
Related Ingredients